Louisiana sues Express Scripts, Ascent over PBM practices

Advertisement

Louisiana Attorney General Liz Murrill has filed a lawsuit against Express Scripts and its affiliate Ascent Health Services, alleging the companies manipulated Louisiana’s prescription drug market.

The state alleges Express Scripts and its partners restricted competition, manipulated pharmacy reimbursement rates, concealed profits and steered patients toward pharmacies they own or control, according to an Aug. 31 news release. Louisiana also alleges Express Scripts entered into an unlawful agreement with Prime Therapeutics, a direct competitor, to coordinate pharmacy reimbursement rates and fees while increasing their collective leverage over drug manufacturers. The state alleges this conduct contributed to higher drug prices, lower reimbursement for independent pharmacies and reduced competition.

The lawsuit seeks damages, civil penalties, attorney’s fees and an injunction prohibiting unlawful conduct under federal and Louisiana law.

Louisiana’s lawsuit lands days after Florida sued Express Scripts and Prime Therapeutics on nearly identical grounds, alleging the two pharmacy benefit managers’ 2019 “collaboration” amounted to illegal horizontal price fixing that slashed pharmacy reimbursement rates. Express Scripts has faced a string of state actions in recent years: Ohio’s attorney general sued the company in 2020 over alleged overcharges to a state retirement system, and Texas named Express Scripts alongside Caremark and Optum Rx in a 2024 lawsuit over insulin pricing. The Louisiana and Florida lawsuits also arrive as states continue passing PBM reform legislation aimed at curbing similar practices nationwide. 

A Prime Therapeutics spokesperson told Becker’s the agreement at issue “has delivered billions of dollars in savings, lowered costs at the pharmacy counter, and maintained broad access to pharmacies for tens of millions of Americans,” and that “rolling back those savings would mean higher costs for patients, employers, health plans and taxpayers who ultimately pay for prescription drugs.”

Becker’s has also reached out to Express Scripts and Ascent Health Services for comment and will update this article if more information becomes available. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement